Activation of caspase-8 in transforming growth factor-beta-induced apoptosis of human hepatoma cells
Y Shima1, K Nakao, T Nakashima
1Department of Clinical Pharmacology, Nagasaki University School of Medicine, Nagasaki, Japan.
Abstract:
Transforming growth factor-beta1 (TGF-beta1) has been shown to induce apoptosis in normal or transformed hepatocytes. To elucidate the biochemical pathways leading to apoptosis induced by TGF-beta1 in human hepatoma cells (HuH-7), we examined the expression of Bcl-2-related proteins and X-chromosome-linked inhibitor of apoptosis (XIAP), and activation of the caspase cascade following TGF-beta1 treatment. Bcl-xL expression began to decline at 12 hours after TGF-beta1 treatment and progressively decreased to very low levels in a time-dependent manner. Bax expression showed a little change throughout the experiment. On the other hand, activation of caspase-8 was clearly observed at 36 hours after TGF-beta1 treatment, followed by activation of caspase-9, and caspase-3 was activated at 48 hours after treatment at which time apoptosis of HuH-7 cells was observed. TGF-beta1 significantly decreased XIAP expression in HuH-7 cells. Addition of an inhibitor of caspase-8 or caspase-3 (IETD-FMK or DEVD-CHO) markedly inhibited TGF-beta1-induced apoptosis of HuH-7 cells. Fas/Fas ligand (FasL) interactions in HuH-7 cells were not involved in the apoptotic process. Furthermore, epidermal growth factor (EGF) also completely inhibited TGF-beta1-induced apoptosis of HuH-7 cells by inhibiting activation of the caspase cascade. Our results suggested that activation of caspase-3 initiated through caspase-8 activation is involved in the apoptotic process induced by TGF-beta1 in HuH-7 cells. Our results also showed that down-regulation of the expression of Bcl-xL and XIAP by TGF-beta1 may facilitate activation of caspase-3 in these cells.
Insights
Transforming growth factor-beta1 (TGF-beta1) induces apoptosis in human hepatoma cells by activating caspase-3, which is facilitated by decreased Bcl-xL and XIAP expression. Epidermal growth factor (EGF) inhibits this TGF-beta1-induced cell death.
Area of Science:
- Cell Biology
- Molecular Biology
- Hepatology
Background:
- Transforming growth factor-beta1 (TGF-beta1) is known to induce apoptosis in hepatocytes.
- Understanding the specific molecular mechanisms is crucial for therapeutic development in liver cancer.
Purpose of the Study:
- To elucidate the biochemical pathways of TGF-beta1-induced apoptosis in human hepatoma (HuH-7) cells.
- To investigate the roles of Bcl-2 family proteins, XIAP, and the caspase cascade.
Main Methods:
- HuH-7 cells were treated with TGF-beta1.
- Expression of Bcl-xL, Bax, and XIAP was analyzed over time.
- Caspase activation (caspase-8, -9, -3) was assessed.
- Apoptosis was quantified, and the effects of caspase inhibitors and EGF were evaluated.
Main Results:
- TGF-beta1 decreased Bcl-xL and XIAP expression in a time-dependent manner.
- Bax expression remained relatively unchanged.
- Caspase-8 activation preceded caspase-9 and caspase-3 activation, correlating with observed apoptosis.
- Caspase inhibitors and EGF significantly blocked TGF-beta1-induced apoptosis.
- Fas/FasL signaling was not involved.
Conclusions:
- TGF-beta1 induces apoptosis in HuH-7 cells primarily through caspase-8 and caspase-3 activation.
- Down-regulation of Bcl-xL and XIAP by TGF-beta1 facilitates caspase-3 activation.
- EGF inhibits TGF-beta1-induced apoptosis by suppressing caspase cascade activation.
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway
Cellular Injury V: Apoptosis and Autophagy


